This article is more than 5 years old. Information may no longer be current.
VIDEO: Ophthalmic surgeons’ skills translatable to Kybella, other aesthetic injectables
Click Here to Manage Email Alerts
WAIKOLOA, Hawaii — Increased emphasis has been placed on minimally invasive cosmetic improvement, an area of expertise adaptable to ophthalmic practice, according to a speaker here.
“I think ophthalmologists are the most adept injectors ... and the skills that you develop in the OR are certainly transferable to a 30-gauge needle,” Steve G. Yoelin, MD, told colleagues at Hawaiian Eye, where he related his own experience of translating his skills as an ophthalmologist to a practice focused on aesthetics.
Among minimally invasive aesthetic treatments, injecting Kybella (ATX-101, Kythera/Allergan) to treat moderate to severe submental fullness is one of the newer procedures Yoelin has undertaken.
ATX-101 was approved by the FDA in June 2015.
“It’s an alternative to liposuction,” Yoelin said. ATX-101 is injected into the pre-platysmal fat where it destroys cell membranes and causes lysis of adipocytes . Furthermore, the inflammatory response will create some skin tightening, he said .
“It’s amazing what you can do with a 30-gauge needle,” he said. – by Patricia Nale, ELS
Reference:
Yoelin SG. Update on neuromodulators. Presented at: Hawaiian Eye; Jan. 16-23, 2016; Waikoloa, Hawaii.
Disclosure: Yoelin reports he is a consultant and speaker for Allergan, Galderma and Kythera/Allergan and has done contracted research for Allergan and Kythera.